e-Drug3D 910 |
cas 55981-09-4 |
CLASS ANTIPARASITIC |
ROUTE (list) ORAL |
PK parameters F 70 PERCENT Solubility PRATICALLY INSOLUBLE IN WATER |
Target TARGET PYRUVATE:FERREDOXIN OXIDOREDUCTASE PDB Ligand code = NTI (link to the list of PDB complexes) Download experimental 3D coordinates of NTI with added hydrogens |
DrugCentral Pyruvate dehydrogenase NADP(+) UNIPROT Q968X7 PFOR Pyruvate:ferredoxin oxidoreductase UNIPROT Q24982 |
Download SDF file | [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate Formula: Calculated chemical properties: MW 307.29 NB_atoms 21 XLogP 0 PSA 99.575 NB_HD 1 NB_HA 7 fsp3 0.08 Lipinski(0=no;1=yes) 1 |
FDA NDA 021498 (pdf not found) INN (NITAZOXANIDE) ALINIA (ROMARK) APPROVAL= AP YEAR= 2002 DISCONTINUED NDA 021497 (pdf not found) INN (NITAZOXANIDE) ALINIA (ROMARK) APPROVAL= AP YEAR= 2004 DISCONTINUED NDA 021818 (pdf not found) INN (NITAZOXANIDE) ALINIA (ROMARK) APPROVAL= AP YEAR= 2005 NEWAPPLICATION NDA 213820 (pdf not found) INN (NITAZOXANIDE) NITAZOXANIDE (RISING) APPROVAL= AP YEAR= 2020 NDA 214844 (pdf not found) INN (NITAZOXANIDE) NITAZOXANIDE (ANI PHARMS) APPROVAL= AP YEAR= 2025 NDA 218701 (pdf not found) INN (NITAZOXANIDE) NITAZOXANIDE (ANNORA PHARMA) APPROVAL= AP YEAR= 2025 |
Other links: |